{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:46:35Z","timestamp":1789055195041,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009193","name":"Marsden Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.nbd.2005.09.001","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T07:22:50Z","timestamp":1130484170000},"page":"568-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Transforming growth factor beta2 haploinsufficient mice develop age-related nigrostriatal dopamine deficits"],"prefix":"10.1016","volume":"21","author":[{"given":"Zane B.","family":"Andrews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Frugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Meguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Grattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Koishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian S.","family":"McLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2005.09.001_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ar.1090940210","article-title":"Estimation of nuclear populations from microtome sections","volume":"94","author":"Abercrombie","year":"1946","journal-title":"Anat. Rec."},{"key":"10.1016\/j.nbd.2005.09.001_bib2","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1210\/endo.142.6.8196","article-title":"Dissociation of prolactin secretion from tuberoinfundibular dopamine activity in late pregnant rats","volume":"142","author":"Andrews","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.nbd.2005.09.001_bib3","first-page":"513","article-title":"Gastric lesions in transforming growth factor beta-1 heterozygous mice","volume":"74","author":"Boivin","year":"1996","journal-title":"Lab. Invest."},{"key":"10.1016\/j.nbd.2005.09.001_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2005.09.001_bib5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2005.09.001_bib6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0014-4886(03)00308-X","article-title":"Transforming growth factor beta 1 may regulate the stability of mature myelin sheaths","volume":"284","author":"Day","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2005.09.001_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nbd.2005.01.010","article-title":"Transforming growth factor beta2 causes an acute improvement in the motor performance of transgenic ALS mice","volume":"19","author":"Day","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2005.09.001_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00429-002-0273-6","article-title":"TGFbeta2 (\u2212\/\u2212) TGFbeta3 (\u2212\/\u2212) double knockout mice display severe midline fusion defects and early embryonic lethality","volume":"206","author":"Dunker","year":"2002","journal-title":"Anat. Embryol."},{"key":"10.1016\/j.nbd.2005.09.001_bib9","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1523\/JNEUROSCI.23-12-05178.2003","article-title":"Development of midbrain dopaminergic neurons in vitro and in vivo","volume":"23","author":"Farkas","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2005.09.001_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(97)00066-X","article-title":"Transforming growth factor-betas in neurodegenerative disease","volume":"54","author":"Flanders","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2005.09.001_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/brain\/awh067","article-title":"The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study","volume":"127","author":"Foltynie","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2005.09.001_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00415-005-0756-5","article-title":"The BDNF Val(66)Met polymorphism has a gender specific influence on planning ability in Parkinson's disease","volume":"252","author":"Foltynie","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2005.09.001_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ng1097-206","article-title":"Increased stress response and beta-phenylethylamine in MAOB-deficient mice","volume":"17","author":"Grimsby","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2005.09.001_bib14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1699-0463.1988.tb00954.x","article-title":"The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis","volume":"96","author":"Gundersen","year":"1988","journal-title":"Acta Pathol. Microbiol. Immunol. Scand."},{"key":"10.1016\/j.nbd.2005.09.001_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0306-4522(00)00084-1","article-title":"TGF-beta2 is anterogradely and retrogradely transported in motoneurons and up-regulated after nerve injury","volume":"97","author":"Jiang","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2005.09.001_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ng1295-415","article-title":"Abnormal lung development and cleft palate in mice lacking TGF-beta3 indicates defects of epithelial\u2013mesenchymal interaction","volume":"11","author":"Kaartinen","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2005.09.001_bib17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0306-4522(94)90583-5","article-title":"Transforming growth factor-beta promotes survival of midbrain dopaminergic neurons and protects them against n-methyl-4-phenylpyridium ion toxicity","volume":"63","author":"Krieglstein","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2005.09.001_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/j.1460-2075.1995.tb07052.x","article-title":"TGF-b superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity","volume":"14","author":"Krieglstein","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2005.09.001_bib19","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1073\/pnas.90.2.770","article-title":"Transforming growth factor-beta1 null mutation in mice causes excessive inflammatory response and early death","volume":"90","author":"Kulkarni","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2005.09.001_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ng1211","article-title":"VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death","volume":"34","author":"Lambrechts","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2005.09.001_bib21","first-page":"559","article-title":"The transforming growth factor-betas: multifaceted regulators of the development and maintenance of skeletal muscles, motoneurons and Schwann cells","volume":"46","author":"McLennan","year":"2002","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.nbd.2005.09.001_bib22","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1095\/biolreprod.103.026179","article-title":"Fetal and maternal transforming growth factor-beta1 may combine to maintain pregnancy in mice","volume":"70","author":"McLennan","year":"2004","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.nbd.2005.09.001_bib23","first-page":"243","article-title":"Prostaglandin synthetase and prostacyclin synthetase in mature rat skeletal muscles: immunohistochemical localisation to arterioles, tendons and connective tissues","volume":"178","author":"McLennan","year":"1991","journal-title":"J. Anat."},{"key":"10.1016\/j.nbd.2005.09.001_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/0023677041958927","article-title":"The use of sodium lamps to brightly illuminate mouse houses during their dark phases","volume":"38","author":"McLennan","year":"2004","journal-title":"Lab. Anim."},{"key":"10.1016\/j.nbd.2005.09.001_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0306-4522(98)00180-8","article-title":"The non-synaptic expression of transforming growth factor-beta 2 is neurally regulated and varies between skeletal muscle fibre types","volume":"87","author":"McLennan","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2005.09.001_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(95)11686-Q","article-title":"Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease","volume":"193","author":"Mogi","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2005.09.001_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2005.09.001_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.parkreldis.2003.12.003","article-title":"Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease","volume":"10","author":"Parsian","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2005.09.001_bib29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000065302","article-title":"Altered renin synthesis and secretion in the kidneys of heterozygous mice with a null mutation in the TGF-beta(2) gene","volume":"10","author":"Pietri","year":"2002","journal-title":"Exp. Nephrol."},{"key":"10.1016\/j.nbd.2005.09.001_bib30","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0896-6273(94)90062-0","article-title":"TGF beta2 and TGF beta3 are potent survival factors for midbrain dopaminergic neurons","volume":"13","author":"Poulsen","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2005.09.001_bib31","first-page":"145","article-title":"Transforming growth factor-beta\u2014Multifunctional regulator of differentiation and development","volume":"327B","author":"Roberts","year":"1990","journal-title":"Philos. Trans. R. Soc. London"},{"key":"10.1016\/j.nbd.2005.09.001_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1044-7431(03)00081-2","article-title":"Transforming growth factor beta1 overexpression in the nigrostriatal system increases the dopaminergic deficit of MPTP mice","volume":"23","author":"Sanchez-Capelo","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2005.09.001_bib33","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1242\/dev.124.13.2659","article-title":"TGF-beta2 knockout mice have multiple developmental defects that are non-overlapping with other TGF-beta knockout phenotypes","volume":"124","author":"Sanford","year":"1997","journal-title":"Development"},{"key":"10.1016\/j.nbd.2005.09.001_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson's disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.nbd.2005.09.001_bib35","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1128\/MCB.23.12.4371-4385.2003","article-title":"Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos","volume":"23","author":"Stenvers","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2005.09.001_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/exnr.1996.0200","article-title":"TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid","volume":"142","author":"Vawter","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2005.09.001_bib37","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1460-9568.2004.03636.x","article-title":"Death of dopaminergic neurones in the rat substantia nigra can be induced by damage to globus pallidus","volume":"20","author":"Wright","year":"2004","journal-title":"Eur. J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996105002457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996105002457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:59:59Z","timestamp":1760849999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996105002457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0969996105002457"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2005.09.001","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming growth factor beta2 haploinsufficient mice develop age-related nigrostriatal dopamine deficits","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2005.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}